- Filed
- Apr 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Mar 31, 2026 | 5.07M sh |
| Capex | FY 2025 · Dec 31, 2025 | $113.02K |
| Capex | FY 2025 · Dec 31, 2024 | $151.62K |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$3.84M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$2.93M |
| Long Term Debt | FY 2025 · Dec 31, 2025 | $31.3K |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $2.16M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $2.51M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $16.28M |
| Stockholders Equity restated | FY 2025 · Dec 31, 2024 | $11.9M |
| Stockholders Equity restated | FY 2025 · Dec 31, 2023 | $8.05M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $34.61M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $63.82M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $34.81M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $67.11M |
| Current Assets | FY 2025 · Dec 31, 2025 | $36.16M |
| Current Assets | FY 2025 · Dec 31, 2024 | $63.02M |
| Total Assets | FY 2025 · Dec 31, 2025 | $51.09M |
| Total Assets | FY 2025 · Dec 31, 2024 | $79.01M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$2.86 |
| Eps Diluted restated | FY 2025 · Dec 31, 2024 | −$2.86 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $11.54M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $9.11M |
| Net Income | FY 2025 · Dec 31, 2025 | −$8.51M |
| Net Income restated | FY 2025 · Dec 31, 2024 | −$5.18M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$4.25M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$834.06K |
| Gross Profit | FY 2025 · Dec 31, 2025 | $9.46M |
| Gross Profit | FY 2025 · Dec 31, 2024 | $8.27M |
| Cost Of Revenue | FY 2025 · Dec 31, 2025 | $307.44M |
| Cost Of Revenue | FY 2025 · Dec 31, 2024 | $274.95M |
| Revenue | FY 2025 · Dec 31, 2025 | $316.9M |
| Revenue | FY 2025 · Dec 31, 2024 | $283.22M |